Published in 2021 this randomized, double-blind, placebo-controlled study was conducted on 46 NAFLD patients. Researchers concluded that supplementation over 12 weeks has a positive impact on patients with NAFLD’s leptin, adiponectin, oxidative stress (expect glutathione peroxidase), and body weight, compared to baseline.
Kooshki F, Moradi F, Karimi A, Niazkar HR, Khoshbaten M, Maleki V, Pourghassem Gargari B. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2021 Oct 1;33(10):1298-1306. doi: 10.1097/MEG.0000000000001830. PMID: 32804855.